{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:54:28Z","timestamp":1795110868253,"version":"4.10.3"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"American Heartworm Society"},{"name":"National Center for Veterinary Parasitology, USA"},{"name":"National Science and Engineering Research Council of Canada","award":["RGPIN-2016-06602"],"award-info":[{"award-number":["RGPIN-2016-06602"]}]},{"DOI":"10.13039\/100018787","name":"Novartis Animal Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012895","name":"Zoetis, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012895","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Since the advent of ivermectin (along with melarsomine and doxycycline), heartworm has come to be viewed as a solved problem in veterinary medicine, diminishing investment into non-clinical research on\n                      <jats:italic>Dirofilaria immitis<\/jats:italic>\n                      . However, heartworm infections continue to pose problems for practitioners and their patients and seem to be increasing in frequency and geographic distribution. Resistance to preventative therapies (macrocyclic lactones) complicates the picture. The use of chemotherapy for other kinds of pathogens has benefitted enormously from research into the basic biology of the pathogen and on the host-pathogen interface. A lack of basic information on heartworms as parasites and how they interact with permissive and non-permissive hosts greatly limits the ability to discover new ways to prevent and treat heartworm disease. Recent advances in technical platforms will help overcome the intrinsic barriers that hamper research on\n                      <jats:italic>D. immitis<\/jats:italic>\n                      , most notably, the need for experimentally infected dogs to maintain the life cycle and provide material for experiments. Impressive achievements in the development of laboratory animal models for\n                      <jats:italic>D. immitis<\/jats:italic>\n                      will enhance efforts to discover new drugs for prevention or treatment, to characterize new diagnostic biomarkers and to identify key parasite-derived molecules that are essential for survival in permissive hosts, providing a rational basis for vaccine discovery. A \u2018genomics toolbox\u2019 for\n                      <jats:italic>D. immitis<\/jats:italic>\n                      could enable unprecedented insight into the negotiations between host and parasite that enable survival in a permissive host. The more we know about the pathogen and how it manipulates its host, the better able we will be to protect companion animals far into the future.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-023-05762-9","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T11:03:03Z","timestamp":1689937383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["New paradigms in research on Dirofilaria immitis"],"prefix":"10.1186","volume":"16","author":[{"given":"Timothy G.","family":"Geary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"key":"5762_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijpddr.2021.03.004","volume":"16","author":"S Noack","year":"2021","unstructured":"Noack S, Harrington J, Carithers DS, Kaminsky R, Selzer PM. Heartworm disease\u2014overview, intervention, and industry perspective. Int J Parasitol Drugs Drug Resist. 2021;16:65\u201389.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5762_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1128\/CMR.00012-12","volume":"25","author":"F Sim\u00f3n","year":"2012","unstructured":"Sim\u00f3n F, Siles-Lucas M, Morch\u00f3n R, Gonz\u00e1lez-Miguel J, Mellado I, Carret\u00f3n E, et al. Human and animal dirofilariasis: the emergence of a zoonotic mosaic. Clin Microbiol Rev. 2012;25:507\u201344.","journal-title":"Clin Microbiol Rev"},{"key":"5762_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/9783527823413.ch10","volume-title":"Human and animal filariases: landscape, challenges, and control","author":"TG Geary","year":"2022","unstructured":"Geary TG, Long A, Tritten L. Current antifilarial drugs \u2013 mechanisms of action. In: Kaminsky R, Geary TG, editors. Human and animal filariases: landscape, challenges, and control. Weinheim: Wiley-VCH; 2022. p. 249\u201382."},{"key":"5762_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/9783527823413.ch8","volume-title":"Human and animal filariases: landscape, challenges, and control","author":"J Ketsis","year":"2022","unstructured":"Ketsis J, Epe C. Antifilarial chemotherapy: current options in veterinary medicine. In: Kaminsky R, Geary TG, editors. Human and animal filariases: landscape, challenges, and control. Weinheim: Wiley-VCH; 2022. p. 191\u2013214."},{"key":"5762_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijpddr.2019.06.002","volume":"10","author":"RK Prichard","year":"2019","unstructured":"Prichard RK, Geary TG. Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistance. Int J Parasitol Drugs Drug Resist. 2019;10:69\u201383.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5762_CR6","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.ijpara.2021.08.006","volume":"51","author":"RK Prichard","year":"2021","unstructured":"Prichard RK. Macrocyclic lactone resistance in Dirofilaria immitis: risks for prevention of heartworm disease. Int J Parasitol. 2021;51:1121\u201332.","journal-title":"Int J Parasitol"},{"key":"5762_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1645\/14-703.1","volume":"101","author":"TG Geary","year":"2015","unstructured":"Geary TG, Sakanari JA, Caffrey CR. Anthelmintic drug discovery: into the future. J Parasitol. 2015;101:125\u201333.","journal-title":"J Parasitol"},{"key":"5762_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijpddr.2020.07.001","volume":"14","author":"SA Nixon","year":"2020","unstructured":"Nixon SA, Welz C, Woods DJ, Costa-Junior L, Zamanian M, Martin RJ. Where are all the anthelmintics? Challenges and opportunities on the path to new anthelmintics. Int J Parasitol Drugs Drug Resist. 2020;14:8\u201316.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5762_CR9","unstructured":"WormBook, The\u00a0C. elegans\u00a0Research Community, editors. http:\/\/www.wormbook.org. Accessed Jan 15 2023."},{"key":"5762_CR10","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/B978-012775390-4\/50245-1","volume-title":"Handbook of animal models of infection","author":"SS Johnson","year":"1999","unstructured":"Johnson SS, Thomas EM, Geary TG. Intestinal worm infections. In: Zak O, Sande M, editors. Handbook of animal models of infection. London: Academic Press, Ltd; 1999. p. 885\u201396."},{"key":"5762_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1084\/jem.173.3.659","volume":"173","author":"FK Nelson","year":"1991","unstructured":"Nelson FK, Greiner DL, Shultz LD, Rajan TV. The immunodeficient scid mouse as a model for human lymphatic filariasis. J Exp Med. 1991;173:659\u201363.","journal-title":"J Exp Med"},{"key":"5762_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2307\/3283709","volume":"78","author":"TV Rajan","year":"1992","unstructured":"Rajan TV, Nelson FK, Cupp E, Schultz LD, Greiner DL. Survival of Onchocerca volvulus in nodules implanted in immunodeficient rodents. J Parasitol. 1992;78:160\u20133.","journal-title":"J Parasitol"},{"key":"5762_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s13071-014-0472-z","volume":"7","author":"A Halliday","year":"2014","unstructured":"Halliday A, Guimaraes AF, Tyrer HE, Metuge HM, Patrick CN, Arnaud KO, et al. A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis. Parasit Vectors. 2014;7:472.","journal-title":"Parasit Vectors"},{"key":"5762_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006977","volume":"12","author":"JB Patton","year":"2018","unstructured":"Patton JB, Bennuru S, Eberhard ML, Hess JA, Torigian A, Lustigman S, et al. Development of Onchocerca volvulus in humanized NSG mice and detection of parasite biomarkers in urine and serum. PLoS Negl Trop Dis. 2018;12:e0006977.","journal-title":"PLoS Negl Trop Dis"},{"key":"5762_CR15","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/s41467-019-09442-0","volume":"10","author":"NP Pionnier","year":"2019","unstructured":"Pionnier NP, Sjoberg H, Chunda VC, Fombad FF, Chounna PW, Njouendou AJ, et al. Mouse models of Loa loa. Nat Commun. 2019;10:1429.","journal-title":"Nat Commun"},{"key":"5762_CR16","unstructured":"Abraham D, Hess J, Bondesen B, Harrington JM. In vivo model for parasitic worm infection and methods for evaluating antiparasitic compounds, including compounds active against canine heartworm. WO 2018.148392 A1, 8 August 2018."},{"key":"5762_CR17","unstructured":"Mills BJ, McTier Tl, Knauer CS, Woods DJ. Anthelmintic laboratory animal model for heartworm. WO 2020\/146338 A1, 16 July 2020."},{"key":"5762_CR18","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41598-023-27537-z","volume":"13","author":"JA Hess","year":"2023","unstructured":"Hess JA, Eberhard ML, Segura-Lepe M, Grundner-Culemann K, Kracher B, Shryock J, et al. A rodent model for Dirofilaria immitis, canine heartworm: parasite growth, development, and drug sensitivity in NSG mice. Sci Rep. 2023;13:976.","journal-title":"Sci Rep"},{"key":"5762_CR19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.immuni.2018.10.016","volume":"49","author":"RM Maizels","year":"2018","unstructured":"Maizels RM, Smits HH, McSorley HJ. Modulation of host immunity by helminths: the expanding repertoire of parasite effector molecules. Immunity. 2018;49:801\u201318.","journal-title":"Immunity"},{"key":"5762_CR20","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ijpara.2020.04.010","volume":"50","author":"J Sotillo","year":"2020","unstructured":"Sotillo J, Robinson MW, Kimber MJ, Cucher M, Ancarola ME, Nejsum P, et al. The protein and microRNA cargo of extracellular vesicles from parasitic helminths - current status and research priorities. Int J Parasitol. 2020;50:635\u201345.","journal-title":"Int J Parasitol"},{"key":"5762_CR21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.molimm.2021.06.017","volume":"137","author":"C Drurey","year":"2021","unstructured":"Drurey C, Maizels RM. Helminth extracellular vesicles: interactions with the host immune system. Mol Immunol. 2021;137:124\u201333.","journal-title":"Mol Immunol"},{"key":"5762_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009828","volume":"15","author":"L Tritten","year":"2021","unstructured":"Tritten L, Ballesteros C, Beech R, Geary TG, Moreno Y. Mining nematode protein secretomes to explain lifestyle and host specificity. PLoS Negl Trop Dis. 2021;15:e0009828.","journal-title":"PLoS Negl Trop Dis"},{"key":"5762_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.869039","volume":"12","author":"B Zhan","year":"2022","unstructured":"Zhan B, Bottazzi ME, Hotez PJ, Lustigman S. Advancing a human onchocerciasis vaccine from antigen discovery to efficacy studies against natural infection of cattle with Onchocerca ochengi. Front Cell Infect Microbiol. 2022;12:869039.","journal-title":"Front Cell Infect Microbiol"},{"key":"5762_CR24","volume-title":"Human and animal filariases: landscape, challenges, and control","author":"D Abraham","year":"2022","unstructured":"Abraham D, Makepeace B, Lustigman S. Development of a vaccine against Onchocerca volvulus. In: Ronald K, Timothy GG, editors. Human and animal filariases: landscape, challenges, and control. Weinheim: Wiley-VCH; 2022."},{"key":"5762_CR25","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/978-1-4615-1823-5_33","volume":"6","author":"RB Grieve","year":"1995","unstructured":"Grieve RB, Wisnewski N, Frank GR, Tripp CA. Vaccine research and development for the prevention of filarial nematode infections. Pharm Biotechnol. 1995;6:737\u201368.","journal-title":"Pharm Biotechnol"},{"key":"5762_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1365-3024.1981.tb00392.x","volume":"3","author":"LS Blair","year":"1981","unstructured":"Blair LS, Campbell WC. Immunization of ferrets against Dirofilaria immitis by means of chemically abbreviated infections. Parasite Immunol. 1981;3:143\u20137.","journal-title":"Parasite Immunol"},{"key":"5762_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4269\/ajtmh.1988.39.373","volume":"39","author":"RB Grieve","year":"1988","unstructured":"Grieve RB, Abraham D, Mika-Grieve M, Seibert BP. Induction of protective immunity in dogs to infection with Dirofilaria immitis using chemically-abbreviated infections. Am J Trop Med Hyg. 1988;39:373\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"5762_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1365-3024.1994.tb00335.x","volume":"16","author":"JS Mejia","year":"1994","unstructured":"Mejia JS, Carlow CK. An analysis of the humoral immune response of dogs following vaccination with irradiated infective larvae of Dirofilaria immitis. Parasite Immunol. 1994;16:157\u201364.","journal-title":"Parasite Immunol"},{"key":"5762_CR29","unstructured":"Fischer L, Moreno Y, Sigoillot-Claude C, Beugnet F. Heartworm vaccine, methods and uses thereof. US Patent 10485857, 26 November 2019."},{"key":"5762_CR30","doi-asserted-by":"publisher","first-page":"20120","DOI":"10.1073\/pnas.1011983107","volume":"107","author":"Y Moreno","year":"2010","unstructured":"Moreno Y, Nabhan JF, Solomon J, Mackenzie CD, Geary TG. Ivermectin disrupts the function of the excretory-secretory apparatus in microfilariae of Brugia malayi. Proc Natl Acad Sci USA. 2010;107:20120\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5762_CR31","doi-asserted-by":"publisher","first-page":"866","DOI":"10.2174\/138920112800399077","volume":"13","author":"TG Geary","year":"2012","unstructured":"Geary TG, Moreno Y. Macrocyclic lactone anthelmintics: spectrum of activity and mechanism of action. Curr Pharmaceut Biotechnol. 2012;13:866\u201372.","journal-title":"Curr Pharmaceut Biotechnol"},{"key":"5762_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10158-016-0190-7","volume":"16","author":"AJ Wolstenholme","year":"2016","unstructured":"Wolstenholme AJ, Maclean MJ, Coates R, McCoy CJ, Reaves BJ. How do the macrocyclic lactones kill filarial nematode larvae? Invert Neurosci. 2016;16:7.","journal-title":"Invert Neurosci"},{"key":"5762_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13071-017-2116-6","volume":"10","author":"DS Carithers","year":"2017","unstructured":"Carithers DS. Examining the role of macrolides and host immunity in combatting filarial parasites. Parasit Vectors. 2017;10:182.","journal-title":"Parasit Vectors"},{"key":"5762_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12036","volume":"10","author":"HJ Loghry","year":"2020","unstructured":"Loghry HJ, Yuan W, Zamanian M, Wheeler NJ, Day TA, Kimber MJ. Ivermectin inhibits extracellular vesicle secretion from parasitic nematodes. J Extracell Vesicles. 2020;10:e12036.","journal-title":"J Extracell Vesicles"},{"key":"5762_CR35","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1080\/14760584.2021.1999810","volume":"20","author":"RM Maizels","year":"2021","unstructured":"Maizels RM. Identifying novel candidates and configurations for human helminth vaccines. Exp Rev Vaccines. 2021;20:1389\u201393.","journal-title":"Exp Rev Vaccines"},{"key":"5762_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002971","volume":"8","author":"L Tritten","year":"2014","unstructured":"Tritten L, Burkman E, Moorhead A, Satti M, Geary J, Mackenzie C, et al. Detection of circulating parasite-derived microRNAs in filarial infections. PLoS-Negl Trop Dis. 2014;8:e0002971.","journal-title":"PLoS-Negl Trop Dis"},{"key":"5762_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vetpar.2016.11.005","volume":"232","author":"L Tritten","year":"2016","unstructured":"Tritten L, Clarke D, Timmins S, McTier T, Geary TG. Dirofilaria immitis exhibits sex- and stage-specific differences in excretory\/secretory miRNA and protein profiles. Vet Parasitol. 2016;232:1\u20137.","journal-title":"Vet Parasitol"},{"key":"5762_CR38","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/pathogens10070786","volume":"10","author":"L Tritten","year":"2021","unstructured":"Tritten L, Burkman EJ, Clark T, Verocai GG. Secretory microRNA profiles of third- and fourth-stage Dirofilaria immitis larvae with different macrocyclic lactone susceptibility: in search of biomarkers for early detection of infection. Pathogens. 2021;10:786.","journal-title":"Pathogens"},{"key":"5762_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.777860","volume":"12","author":"A Wiszniewsky","year":"2021","unstructured":"Wiszniewsky A, Layland LE, Arndts K, Wadephul LM, Tamadaho RSE, Borrero-Wolff D, et al. Adoptive transfer of immune cells into RAG2IL-2R\u03b3-deficient mice during Litomosoides sigmodontis infection: a novel approach to investigate filarial-specific immune responses. Front Immunol. 2021;12:777860.","journal-title":"Front Immunol"},{"key":"5762_CR40","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines\u2014a new era in vaccinology. Nat Rev Drug Discov. 2018;17:261\u201379.","journal-title":"Nat Rev Drug Discov"},{"key":"5762_CR41","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","volume":"40","author":"AJ Barbier","year":"2022","unstructured":"Barbier AJ, Jiang AY, Zhang P, Wooster R, Anderson DG. The clinical progress of mRNA vaccines and immunotherapies. Nat Biotechnol. 2022;40:840\u201354.","journal-title":"Nat Biotechnol"},{"key":"5762_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1146\/annurev-bioeng-110220-031722","volume":"24","author":"J Chen","year":"2022","unstructured":"Chen J, Chen J, Xu Q. Current developments and challenges of mRNA vaccines. Annu Rev Biomed Eng. 2022;24:85\u2013109.","journal-title":"Annu Rev Biomed Eng"},{"key":"5762_CR43","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/bs.ircmb.2022.04.011","volume":"372","author":"M Li","year":"2022","unstructured":"Li M, Wang Z, Xie C, Xia X. Advances in mRNA vaccines. Int Rev Cell Mol Biol. 2022;372:295\u2013316.","journal-title":"Int Rev Cell Mol Biol"},{"key":"5762_CR44","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1586\/eri.11.76","volume":"9","author":"TG Geary","year":"2011","unstructured":"Geary TG, Mackenzie CD. Progress and challenges in the discovery of macrofilaricidal drugs. Exp Rev Anti-infect Ther. 2011;9:681\u201395.","journal-title":"Exp Rev Anti-infect Ther"},{"key":"5762_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ijpddr.2022.06.002","volume":"19","author":"N Hawryluk","year":"2022","unstructured":"Hawryluk N, Zhiru L, Carlow C, Gokool S, Townson S, Kreiss T, et al. Filarial nematode phenotypic screening cascade to identify compounds with anti-parasitic activity for drug discovery optimization. Int J Parasitol Drugs Drug Resist. 2022;19:89\u201397.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5762_CR46","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/9783527823413.ch15","volume-title":"Human and animal filariases: landscape, challenges, and control","author":"L Rufener","year":"2022","unstructured":"Rufener L, Vernudachi A, Kaminsky R, Duguet T. Discovery and development of new antifilarial drugs (in vitro assays). In: Kaminsky R, Geary TG, editors. Human and animal filariases: landscape, challenges, and control. Weinheim: Wiley-VCH; 2022. p. 367\u201390."},{"key":"5762_CR47","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/9783527823413.ch16","volume-title":"Human and animal filariases: landscape, challenges, and control","author":"S Schorderet-Weber","year":"2022","unstructured":"Schorderet-Weber S, Specht S. In vivo models for the discovery of new antifilarial drugs. In: Kaminsky R, Geary TG, editors. Human and animal filariases: landscape, challenges, and control. Weinheim: Wiley-VCH; 2022. p. 391\u2013458."},{"key":"5762_CR48","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/9783527823413.ch17","volume-title":"Human and animal filariases: landscape, challenges, and control","author":"H Sager","year":"2022","unstructured":"Sager H, Lizundia R, White WH. In vivo assays: discovery and development of new antifilarial drugs in companion animals. In: Kaminsky R, Geary TG, editors. Human and animal filariases: landscape, challenges, and control. Weinheim: Wiley-VCH; 2022. p. 459\u201379."},{"key":"5762_CR49","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/00034983.1996.11813075","volume":"90","author":"SK Tagboto","year":"1996","unstructured":"Tagboto SK, Townson S. Onchocerca volvulus and O. lienalis: the microfilaricidal activity of moxidectin compared with that of ivermectin in vitro and in vivo. Ann Trop Med Parasitol. 1996;90:497\u2013505.","journal-title":"Ann Trop Med Parasitol."},{"key":"5762_CR50","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s42003-020-01128-4","volume":"3","author":"S Verma","year":"2020","unstructured":"Verma S, Kashyap SS, Robertson AP, Martin RJ. Diethylcarbamazine activates TRP channels including TRP-2 in filaria, Brugia malayi. Commun Biol. 2020;3:398.","journal-title":"Brugia malayi Commun Biol"},{"key":"5762_CR51","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijpddr.2022.10.002","volume":"20","author":"SS Kashyap","year":"2022","unstructured":"Kashyap SS, McHugh MA, Robertson AP, Martin RJ. Diethylcarbamazine mediated potentiation of emodepside induced paralysis requires TRP-2 in adult Brugia malayi. Int J Parasitol Drugs Drug Resist. 2022;20:108\u201312.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5762_CR52","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ijpddr.2021.12.001","volume":"18","author":"S Choudhary","year":"2022","unstructured":"Choudhary S, Kashyap SS, Martin RJ, Robertson AP. Advances in our understanding of nematode ion channels as potential anthelmintic targets. Int J Parasitol Drugs Drug Resist. 2022;18:52\u201386.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5762_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpddr.2020.12.002","volume":"15","author":"S Verma","year":"2021","unstructured":"Verma S, Kulke D, McCall JW, Martin RJ, Robertson AP. Recording drug responses from adult Dirofilaria immitis pharyngeal and somatic muscle cells. Int J Parasitol Drugs Drug Resist. 2021;15:1\u20138.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5762_CR54","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/bs.apar.2016.02.012","volume":"93","author":"AC Kotze","year":"2016","unstructured":"Kotze AC, Prichard RK. Anthelmintic resistance in Haemonchus contortus: history, mechanisms and diagnosis. Adv Parasitol. 2016;93:397\u2013428.","journal-title":"Adv Parasitol"},{"key":"5762_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111522","volume":"41","author":"SR Doyle","year":"2022","unstructured":"Doyle SR, Laing R, Bartley D, Morrison A, Holroyd N, Maitland K, et al. Genomic landscape of drug response reveals mediators of anthelmintic resistance. Cell Rep. 2022;41:111522.","journal-title":"Cell Rep"},{"key":"5762_CR56","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.vetpar.2015.04.002","volume":"210","author":"C Bourguinat","year":"2015","unstructured":"Bourguinat C, Lee AC, Lizundia R, Blagburn BL, Liotta JL, Kraus MS, et al. Macrocyclic lactone resistance in Dirofilaria immitis: Failure of heartworm preventives and investigation of genetic markers for resistance. Vet Parasitol. 2015;210:167\u201378.","journal-title":"Vet Parasitol"},{"key":"5762_CR57","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ijpddr.2018.06.006","volume":"8","author":"C Ballesteros","year":"2018","unstructured":"Ballesteros C, Pulaski CN, Bourguinat C, Keller K, Prichard RK, Geary TG. Clinical validation of molecular markers of macrocyclic lactone resistance in Dirofilaria immitis. Int J Parasitol Drugs Drug Resist. 2018;8:596\u2013606.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5762_CR58","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/9783527823413.ch23","volume-title":"Human and animal filariases: landscape, challenges, and control","author":"S Todorovic","year":"2022","unstructured":"Todorovic S, McKay T, Kaufman P. Vector control strategies for canine filariasis. In: Kaminsky R, Geary TG, editors. Human and animal filariases: landscape, challenges, and control. Weinheim: Wiley-VCH; 2022. p. 565\u201388."},{"key":"5762_CR59","doi-asserted-by":"publisher","first-page":"206482","DOI":"10.1242\/jeb.206482","volume":"223","author":"ML Castelletto","year":"2020","unstructured":"Castelletto ML, Gang SS, Hallem EA. Recent advances in functional genomics for parasitic nematodes of mammals. J Exp Biol. 2020;223:206482.","journal-title":"J Exp Biol"},{"key":"5762_CR60","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0166-6851(03)00092-6","volume":"129","author":"AA Aboobaker","year":"2003","unstructured":"Aboobaker AA, Blaxter ML. Use of RNA interference to investigate gene function in the human filarial nematode parasite Brugia malayi. Mol Biochem Parasitol. 2003;129:41\u201351.","journal-title":"Mol Biochem Parasitol"},{"key":"5762_CR61","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1756-3305-5-16","volume":"13","author":"F Landmann","year":"2012","unstructured":"Landmann F, Foster JM, Slatko BE, Sullivan W. Efficient in vitro RNA interference and immunofluorescence-based phenotype analysis in a human parasitic nematode, Brugia malayi. Parasit Vectors. 2012;13:16.","journal-title":"Parasit Vectors"},{"key":"5762_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001239","volume":"6","author":"C Song","year":"2010","unstructured":"Song C, Gallup JM, Day TA, Bartholomay LC, Kimber MJ. Development of an in vivo RNAi protocol to investigate gene function in the filarial nematode Brugia malayi. PloS-Pathog. 2010;6:e1001239.","journal-title":"PloS-Pathog"},{"key":"5762_CR63","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0014-4894(02)00004-8","volume":"100","author":"TB Higazi","year":"2002","unstructured":"Higazi TB, Merriweather A, Shu L, Davis R, Unnasch TR. Brugia malayi: transient transfection by microinjection and particle bombardment. Exp Parasitol. 2002;100:95\u2013102.","journal-title":"Exp Parasitol"},{"key":"5762_CR64","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ijpara.2010.10.005","volume":"41","author":"S Xu","year":"2011","unstructured":"Xu S, Liu C, Tzertzinis G, Ghedin E, Evans CC, Kaplan R, et al. In vivo transfection of developmentally competent Brugia malayi infective larvae. Int J Parasitol. 2011;41:355\u201362.","journal-title":"Int J Parasitol"},{"key":"5762_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006509","volume":"12","author":"C Liu","year":"2018","unstructured":"Liu C, Mhashilkar AS, Chabanon J, Xu S, Lustigman S, Adams JH, et al. Development of a toolkit for piggyBac-mediated integrative transfection of the human filarial parasite Brugia malayi. PLoS Negl Trop Dis. 2018;12:e0006509.","journal-title":"PLoS Negl Trop Dis"},{"key":"5762_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008627","volume":"14","author":"C Liu","year":"2020","unstructured":"Liu C, Grote A, Ghedin E, Unnasch TR. CRISPR-mediated transfection of Brugia malayi. PLoS Negl Trop Dis. 2020;14:e0008627.","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-023-05762-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-023-05762-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-023-05762-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T11:04:35Z","timestamp":1689937475000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-023-05762-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5762"],"URL":"https:\/\/doi.org\/10.1186\/s13071-023-05762-9","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"assertion":[{"value":"1 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None necessary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None necessary.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author is a consultant for Zoetis, Inc., Boehringer-Ingelheim Animal Health and Elanco and is on the Scientific and Technical Advisory Board of Animol, Inc. None of these entities had any input into or oversight of that contents of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"247"}}